L01 - Novel 5-HT7 antagonists for the treatment of migraine
Dr Ali ATES
UCB, Braine-l'Alleud, Belgium
L06 - Métabolomique et Chimie Médicinale, vers la découverte de nouvelles cibles thérapeutiques potentielles : application à la Dégénérescence Maculaire Liée à l’Age (DMLA)
Dr Pascal DE TULLIO
ULG, Liege, Belgium
L04 - Development of cyclin dependent kinase inhibitors. Investigation of their molecular mechanism of action
Prof. Hervé GALONS
SCT & PARIS DESCARTES UNIVERSITY, Paris, France
L02 - Foldamers: Expanding the Chemical Space
Dr Ivan HUC
IECB & CNRS - UNIVERSITÉ DE BORDEAUX, Bordeaux, France
L03 - Promoting Immune Rejection of Tumors by Blocking Tryptophan Catabolism by IDO and TDO
Prof. Benoît VAN DEN EYNDE
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, UCL, DE DUVE INSTITUTE, Bruxelles, Belgium
L05 - 3D pharmacophores in computational drug design: tools for hit discovery and lead optimization